Evidence map›Paper›PMID 42578853›Full record

ArticleAnalytical chemistry2026

Rapid Chiral Analysis of Drugs with Multiple Stereocenters via High-Resolution Ion Mobility.

Benjamin K Blakley, Jody C May, Valeria Guidolin, Bao Nguyen, John A McLean

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin K BlakleyDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee37235-1822, United States.ORCID 0009-0003-3263-5289
Jody C MayDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee37235-1822, United States.ORCID 0000-0003-4871-5024
Valeria GuidolinPfizer, Inc., Pharmaceutical Sciences Small Molecules (PSSM), Groton, Connecticut06340, United States.
Bao NguyenPfizer, Inc., Pharmaceutical Sciences Small Molecules (PSSM), Groton, Connecticut06340, United States.
John A McLeanDepartment of Chemistry, Center for Innovative Technology, Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, and Vanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, Tennessee37235-1822, United States.ORCID 0000-0001-8918-6419

Funding

Vanderbilt University NA
6 · The paper itself

Abstract

The increasing structural complexity of small-molecule therapeutics requires sensitive analytical techniques that facilitate rapid chiral analysis of drugs with multiple chiral centers. Here, we demonstrate ultrafast chiral separations for compounds possessing 3 chiral centers (8 stereoisomers, 4 enantiomer pairs) using gas-phase ion mobility spectrometry-mass spectrometry (IM-MS). Separations are achieved using spontaneous noncovalent copper-tyrosine complexation.This complexation strategy converts all stereoisomers into diastereomers that are structurally distinguishable by IM-MS. Notably, this strategy is over 3 orders of magnitude faster than traditional liquid-phase chiral chromatography (ms vs min, respectively). Using IM-MS, we achieved direct baseline separation of enantiomer pairs and progress toward differentiation of all 8 stereoisomers. Results suggest that higher-order complexes (i.e., copper-tyrosine-bound drug dimers) enhance chiral differentiation at the expense of increased spectral complexity. Exchanging the chirality of the amino acid for complexation resulted in an inversion of separation elution ordering. Peak fitting analysis suggests that an IM resolving power of several thousand is necessary to resolve all stereoisomers for quantitative purposes, which is approximately an order of magnitude higher than the current state-of-the-art. Collectively, these findings demonstrate the speed and versatility of gas-phase ion mobility spectrometry for complex chiral analysis.

Indexed as

Ion Mobility SpectrometryCopperMass SpectrometryPharmaceutical PreparationsStereoisomerismTyrosineCopperPharmaceutical PreparationsTyrosine

Identifiers

PMID42578853
PMCPMC13470978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.